851314-54-0

Basic information

• Product Name: N-(1H-Benzotriazol-1-ylmethyl)-N-(phenylmethyl)-beta-alanine ethyl ester
• Synonyms: N-(1H-Benzotriazol-1-ylmethyl)-N-(phenylmethyl)-beta-alanine ethyl ester
• CAS NO: 851314-54-0
• Molecular Weight: 338.409
• Mol File: 851314-54-0.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: N-(1H-Benzotriazol-1-ylmethyl)-N-(phenylmethyl)-beta-alanine ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: N-(1H-Benzotriazol-1-ylmethyl)-N-(phenylmethyl)-beta-alanine ethyl ester(851314-54-0)
• EPA Substance Registry System: N-(1H-Benzotriazol-1-ylmethyl)-N-(phenylmethyl)-beta-alanine ethyl ester(851314-54-0)

Safety Data

• Hazardous Substances Data: 851314-54-0(Hazardous Substances Data)

Upstream product

• 95-14-7 1,2,3-Benzotriazole 
• 23583-21-3 ethyl-3-benzylamino propionate 
• 50-00-0 formaldehyd 

Downstream Products

• 851314-55-1 ethyl N-[3-(ethyloxy)-2,2-difluoro-3-oxopropyl]-N-(phenylmethyl)-beta-alaninate 
• 1067915-34-7 ethyl 1-benzyl-5,5-difluoro-4-oxopiperidine-3-carboxylate 
• 1067914-81-1 3,3-difluoro-1-(phenylmethyl)-4,4-piperidinediol 
• 851314-50-6 4-{4-[3-(2-chloro-3,6-difluorophenoxy)propyl]phenyl}-5,5-difluoro-5,6-dihydro-2H-pyridine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester 
• 851314-44-8 1-benzyl-4-{4-[3-(tert-butyldimethylsilanyloxy)propyl]phenyl}-5,5-difluoro-1,2,5,6-tetrahydro-pyridine-3-carboxylic acid ethyl ester 
• 851314-47-1 5,5-difluoro-4-[4-(3-hydroxypropyl)phenyl]-5,6-dihydro-2H-pyridine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester 
• 851314-41-5 1-benzyl-5,5-difluoro-4-trifluoromethanesulfonyloxy-1,2,5,6-tetrahydro-pyridine-3-carboxylic acid ethyl ester 
• 1233932-22-3 8-benzyl-6,6-difluoro-4-(phenylsulfonyl)-1-oxa-4,8-diazaspiro[4.5]decane 
• 851314-56-2 ethyl 5,5-difluoro-4-hydroxy-1-(phenylmethyl)-1,2,5,6-tetrahydro-3-pyridinecarboxylate 

Relevant articles and documents

5-SUBSTITUTED DIFLUOROPIPERIDINE COMPOUND CAPABLE OF PASSING THROUGH BLOOD-BRAIN BARRIER

The present invention discloses 5-substituted difluoropiperidine compounds having a capacity to cross the blood-brain barrier; the compound has the structural formula represented by formula (I): The 5-substituted difluoropiperidine compounds, derivatives

Quinazoline derivative salt-type crystal forms and preparation method and application thereof

The invention discloses quinazoline derivative salt-type crystal forms and a preparation method and application thereof. The quinazoline derivative salt-type crystal forms are specifically the hydrochloride crystal forms A, B, C, D, F, H, I, the sulphate

PIPERIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS

Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.